Advertisement
U.S. Markets open in 2 hrs 52 mins
S&P Futures
5,895.00 -25.00 (-0.42%) Dow Futures
43,288.00 -252.00 (-0.58%) Nasdaq Futures
20,565.75 -67.75 (-0.33%) Russell 2000 Futures
2,291.70 -26.00 (-1.12%) Crude Oil
68.60 -0.56 (-0.81%) Gold
2,639.20 +24.60 (+0.94%)
BioInvent International AB (BIX0.DU)
Dusseldorf - Dusseldorf Delayed Price. Currency in EUR
Follow
As of 09:31AM CET. Market open.
| Previous Close | 4.0250 |
| Open | 4.0250 |
| Bid | 3.8550 x N/A |
| Ask | 3.9600 x N/A |
| Day's Range | 4.0250 - 4.0350 |
| 52 Week Range | 1.2520 - 4.2900 |
| Volume | |
| Avg. Volume | 0 |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | Oct 31, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ACCESSWIREBioInvent International AB: Interim Report January-September 2024
LUND, SWEDEN / ACCESSWIRE / October 31, 2024 / BioInvent International (STO:BINV) "Progress to date brings the company one step closer to addressing the needs for new treatment solutions for patients. As part of our Q3 report, we are today pleased ...
- ACCESSWIRE
Invitation to Presentation of BioInvent’s Interim Report January - September 2024
LUND, SE / ACCESSWIRE / October 29, 2024 / BioInvent International (STO:BINV) BioInvent International AB ("BioInvent") (Nasdaq Stockholm: BINV) invites investors, analysts and the press to a presentation of the interim report January- September 2024 ...
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.